It is actually authorised for intravenous use in conditions like alcoholic fatty liver, fibrosis, cirrhosis, and alcoholic hepatitis and sometimes to neutralise the toxicity from chemotherapy, Dr Dhir added
The connection remains investigational, and any effects on alcohol consumption should be considered preliminary findings requiring rigorous clinical validation
Monitoring and Discontinuation: Users should monitor their response to BPC-157 and discontinue use if any concerning symptoms develop
Focus on Bioavailability If you are drinking, your bodys demand for glutathione is higher
Minimizing stress is one of the most important areas to prevent depletion of glutathione
BPI Labs, like all compounders, faces pressure to demonstrate consistent quality and compliance